04/24/2024 6:05 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
04/18/2024 6:00 AM | RedHill Biopharma (Filer)
| Form POS AM | |
04/08/2024 8:25 AM | RedHill Biopharma (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/08/2024 8:28 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 3:05 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2024 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/02/2024 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 3:38 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024 7:54 AM | RedHill Biopharma (Filer)
| Form 424B3 | |
02/15/2024 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
02/09/2024 3:20 PM | RedHill Biopharma (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
02/05/2024 7:00 AM | RedHill Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/01/2024 9:22 AM | CVI Investments, Inc. (Filed by) RedHill Biopharma (Subject)
| Form SC 13G | |
01/26/2024 11:50 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/26/2024 8:29 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
01/26/2024 8:31 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024 8:09 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024 5:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 9:23 AM | Empery Asset Management, LP (Filed by) RedHill Biopharma (Subject)
| Form SC 13G/A | |
01/02/2024 3:26 PM | RedHill Biopharma (Subject) SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/20/2023 7:45 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023 3:10 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023 11:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
10/26/2023 3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
10/23/2023 3:06 PM | RedHill Biopharma (Filer)
| Form F-3/A | |
10/16/2023 3:05 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/13/2023 7:13 AM | RedHill Biopharma (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
10/12/2023 3:05 PM | RedHill Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/10/2023 8:08 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023 7:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023 3:17 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
09/18/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/17/2023 6:07 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2023 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
08/11/2023 3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
08/09/2023 8:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2023 8:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023 6:04 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023 12:31 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023 12:33 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023 11:09 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023 7:00 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
07/21/2023 8:37 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/21/2023 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023 6:10 AM | RedHill Biopharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/12/2023 7:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2023 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/04/2023 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2023 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2023 6:07 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2023 6:07 AM | RedHill Biopharma (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |